Skip to main content
. 2025 Feb 4;19:373–383. doi: 10.2147/OPTH.S493398

Table 1.

Baseline Characteristics of the Study Population, Surgical Details and IOL Material

Parameter Uveitis (Eyes, n=52) No Uveitis (Eyes, n=38) p-value
Sex, n (%)
 Female (patients) 21/34 (61.8) 16/22 (72.7) 0.56a
 Female (eyes) 33/52 (63.5) 28/38 (73.7) 0.37a
Age at surgery, y (eye) mean ± SD 66 ± 10 74 ± 8 <0.001b
Glaucoma, n (eyes; %) 2 (3.8) 3 (7.9) 0.65a
Pseudoexfoliations, n (eyes; %) 5 (9.6) 5 (13.2) 0.59a
Coexisting pathology, n (eyes; %) 8 (15.4) 11 (28.9) 0.19a
LOCS III, median (IQR)
 Nuclear opalescence 3.5 (3.0–4.4) 4.0 (3.5–4.5) 0.15c
 Nuclear color 3.5 (3.0–4.5) 4.0 (2.9–4.5) 0.49c
 Cortical 2.5 (1.0–3.2) 2.0 (1.5–3.0) 0.81c
 Posterior subcapsular 2.5 (1.5–3.5) 1.5 (1.0–2.5) 0.003c
Bilateral surgery, n (patients; %) 36 (69.2) 32 (84.2) 0.14a
Capsular stain, n (eyes; %) 10 (19.2) 2 (5.3) 0.07a
Mechanical pupil dilation, n (eyes; %) 15 (28.8) 0 <0.001a
Capsular hooks, n (eyes; %) 1 (1.9) 0 >0.99a
Capsular tension ring, n (eyes; %) 0 1 (2.6) 0.42a
Posterior capsular rupture 0 0 NA
IOL material
 Hydrophobic, n (eye; %) 25 (48.1) 20 (52.6) 0.83a
 Hydrophilic, n (eye; %) 27 (51.9) 18 (47.4)

Notes: aFisher´s exact test, bIndependent samples t-test, cMann–Whitney U test.

Abbreviations: IOL, intraocular lens; IQR, interquartile range; LOCS, Lens Opacities Classification System; NA, not applicable; SD, standard deviation; y, years.